- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/62 - DNA sequences coding for fusion proteins
Patent holdings for IPC class C12N 15/62
Total number of patents in this class: 10798
10-year publication summary
|
461
|
541
|
851
|
789
|
861
|
1015
|
1053
|
879
|
926
|
675
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20842 |
161 |
| The Trustees of the University of Pennsylvania | 4432 |
98 |
| President and Fellows of Harvard College | 6110 |
78 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3014 |
75 |
| The Board of Trustees of the Leland Stanford Junior University | 6697 |
69 |
| The Broad Institute, Inc. | 1990 |
60 |
| Regeneron Pharmaceuticals, Inc. | 4790 |
59 |
| The General Hospital Corporation | 4879 |
57 |
| Centre National de La Recherche Scientifique | 11077 |
44 |
| Sangamo Therapeutics, Inc. | 379 |
43 |
| The Johns Hopkins University | 5922 |
40 |
| Massachusetts Institute of Technology | 10285 |
39 |
| National Research Council of Canada | 1549 |
39 |
| Novartis AG | 10175 |
37 |
| F. Hoffmann-La Roche AG | 7800 |
35 |
| Monsanto Technology LLC | 8575 |
35 |
| Board of Regents, The University of Texas System | 6149 |
35 |
| JCR Pharmaceuticals Co., Ltd. | 226 |
35 |
| Memorial Sloan-Kettering Cancer Center | 2056 |
35 |
| University Health Network | 1068 |
33 |
| Other owners | 9691 |